meglumine has been researched along with Phobic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brizzi, D; Calabrese, M; Carbonaro, L; Chiaramondia, M; Kirchin, MA; Sardanelli, F | 1 |
| Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG | 1 |
1 trial(s) available for meglumine and Phobic Disorders
| Article | Year |
|---|---|
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome | 1995 |
1 other study(ies) available for meglumine and Phobic Disorders
| Article | Year |
|---|---|
Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Contrast Media; Equipment Design; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Overweight; Phobic Disorders; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2009 |